CEO at WSA: No clarity on EQT exit plans yet

The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.

Photo: WS Audiology / PR

Hearing aid manufacturer WS Audiology (WSA) became a reality in 2019 when the merger of Danish company Widex and Sivantos, which was at the time owned by EQT, received final approvals.

Ownership of WSA is now split between EQT and the Tøpholm and Westermann families, the owners of Widex. The families hold 51 percent of the shares while EQT, through a new fund, owns 49 percent of the shares, after EQT sold 4 percent of shares to T&W Medical in January.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Lundbeck chairman demands change: "We can't live with this"

Years of work developing new treatments at Lundbeck has so far come to nothing. This has led chairman Lars Rasmusssen to demand visible results, even though CEO Deborah Dunsire has essentially had to restart development work since she joined the firm in 2018.

Eli Lilly upgrades earnings per share guidance

On Tuesday, US-based pharmaceutical firm Eli Lilly has updated elements of its 2021 financial guidance pertaining to earnings per share (non-GAAP), now expecting USD 7.95-8.05 compared to the previous USD 7.8-8.

Further reading

Related articles

Trial banner

Latest news

See all jobs